SCHEDULE 13D/A Filed 2026-08-25 Event 2026-08-21 SEC 0001171843-26-005738 →

Nijhawan Pardeep → EDESA BIOTECH, INC. EDSA

Stake: — Shares: 1,164,676 Class: Common Shares, no par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 5.85

208,955 shares short · -3.4% vs prior

Other 13D/G Filings on EDESA BIOTECH, INC.

Filed	Form	Filer	Stake	Shares
2026-08-25	SCHEDULE 13D/A	Velan Capital Investment Management LP	—	1,081,385	view →
2026-06-18	SCHEDULE 13G	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →
2026-06-16	SCHEDULE 13D/A	Nijhawan Pardeep	—	1,164,676	view →
2025-02-14	SCHEDULE	Nijhawan Pardeep	19.99%	1,596,581	view →
2020-01-23	SC	10379085 Canada Inc.	—	—	view →
2020-01-16	SC	Pardeep Nijhawan Medicine Professional Corp	—	—	view →
2020-01-16	SC	Lumira Capital Investment Management Inc.	—	—	view →
2019-09-10	SC	10379085 Canada Inc.	—	—	view →
2019-09-10	SC	Inveready Innvierte Biotech II, S.C.R. S.A	—	—	view →

Other Filings by Nijhawan Pardeep

Filed	Form	Issuer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	EDESA BIOTECH, INC. EDSA	—	1,164,676	view →
2025-02-14	SCHEDULE	Edesa Biotech, Inc. EDSA	19.99%	1,596,581	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →